Assistant Professor of Medicine, Brigham and Women's Hospital
Rheumatology
Dr. Peter Nigrovic, MD
|
|
Give Review
Dr. Peter Nigrovic works in the field of Rheumatology. He went to medical school at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received 4 awards: "Regional Top Doctor", "Fellow", "Fellow (FACR)" and "Super Doctor". Peter Nigrovic is a published MD. He has 46 papers published. The most current publication "Increased pretreatment serum IFN-/ ratio predicts non-response to tumour necrosis factor inhibition in rheumatoid arthritis." He accepts all Medicare patients.
Publications
- Editorial: 21st Century Storm Chasers: Defining Macrophage Activation Syndrome.
- Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid Arthritis.
- MICL controls inflammation in rheumatoid Arthritis.
- Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation.
- IL-33/ST2 axis promotes mast cell survival via BCLXL.
- Review: is there a window of opportunity for treatment of systemic juvenile idiopathic Arthritis?
- Choosing Wisely: The American College of Rheumatology's Top 5 for Pediatric Rheumatology.
- Adding canakinumab to the childhood Arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic Arthritis.
- Transition and transfer of adolescents and young adults with pediatric onset chronic Disease: The patient and parent perspective.
- Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid Arthritis.
- 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of...
- Sweets are good for you: Fine tuning antibodies via glycosylation.
- PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid Arthritis.
- Ly6 family proteins in neutrophil biology.
- Shrinking Lung Syndrome as a Manifestation of Pleuritis: A New Model Based on Pulmonary Physiological Studies.
- The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes.
- Platelets: active players in the pathogenesis of Arthritis and SLE.
- Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on micropar...
- Extreme thrombocytosis predicts Kawasaki Disease in infants.
- Patients with juvenile psoriatic Arthritis comprise two distinct populations.
- Subpopulations within juvenile psoriatic Arthritis: a review of the literature.
- Mast cells contribute to initiation of autoantibody-mediated Arthritis via IL-1.
- Synovial mast cells: role in acute and chronic Arthritis.
- Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic Arthritis.
- Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer Arthritis.
- Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.
- Mast cells contribute to autoimmune inflammatory Arthritis via their tryptase/heparin complexes.
- Juvenile psoriatic Arthritis: bathwater or baby?
- Platelets amplify inflammation in Arthritis via collagen-dependent microparticle production.
- Neutrophils in a mouse model of autoantibody-mediated Arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated anti...
- Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1).
- C5a receptor enables participation of mast cells in immune complex Arthritis independently of Fc? receptor modulation.
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic Arthritis: report of forty-six patients from an international multicenter series.
- Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency.
- Raynaud's phenomenon in children: a retrospective review of 123 patients.
- Mast cells in inflammatory Arthritis.
- Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic Arthritis.
- Particularities of the vasculature can promote the organ specificity of autoimmune attack.
- Neutrophil-derived leukotriene B4 is required for inflammatory Arthritis.
- Care of the adult with juvenile rheumatoid Arthritis.
- Mast cells in autoantibody responses and Arthritis.
- Treatment of TRAPS with etanercept: use in pediatrics.
- Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic Arthritis.
- Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic Arthritis: histology of an established clinical entity.
- Evaluation of synovial mast cell functions in autoimmune Arthritis.
Schools
HARVARD MED SCH
Massachusetts General Hospital
The Brigham And Women39S Hospital
The Chldrns Hospital
Procedures Preformed
- Joint Drainage
Conditions Treated
- Arthritis
- Behçet's Disease
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- View All
Doctors Specialties
- Pediatric Rheumatology
- Rheumatology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow
- Fellow (FACR)
- Super Doctor
Education
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1154388528 | |
| NPPES Provider LastName | NIGROVIC | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 200.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 23.0 | |
| Percent Opioid Claims | 11.5 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154388528 |
| Last Name Of The Provider | NIGROVIC |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
|
Dr. Richard P. Polisson, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael B. Brenner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kichul Shin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irit Tirosh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack F. Bukowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Stone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasileios Kyttaris, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Steven R. Goldring, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mary Beth Son, MD |
|
|
Dr. Janice Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert P. Sundel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald B. Miley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Malgorzata I. Dawiskiba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc D. Natter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gunnar Tomasson, MD
This Doctor is OpenDoctor Recommended.
|